Regulators will review data form the TULIP trial, showing the antibody-drug conjugate had a progression-free survival advantage versus physician's choice of treatment.
Global Roundup: Takeda and PeptiDream Expand CNS Collaboration biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.
BioSpace Movers & Shakers, July 16 biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.